Search

everythinglearnresearchcommunity

for

Search:↓

Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Fetal ovaries produce different hormones than adult ovaries, and endocrine-disrupting chemicals may affect this process.

DHT deficiency can disrupt cell connections in rat testes, possibly affecting fertility.

Sebaceous glands age due to genetic and environmental factors, affecting sebum production and composition.

Dahuang-Gancao Decoction improves hair growth in androgenetic alopecia.

Human skin has less GDNF and its receptor with age.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

Hormonal therapy is essential in late-diagnosed Kallmann's syndrome to prevent bone issues.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Ovarian hyperthecosis can cause symptoms even with normal testosterone levels, and surgery can improve these symptoms.

Ovarian thecomas can cause virilization in postmenopausal women and are treated with surgery.

Early detection of ovarian steroid cell tumors is crucial to prevent lasting symptoms.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Progesterone protects brain cells by converting to allopregnanolone and involving GABAA receptors.

A new treatment for hair loss shows promise with fewer side effects.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

DHT deficiency in rats reduces sperm content and affects testis structure over time.

A rare ovarian tumor was diagnosed in a woman from North Brazil, and surgery is the preferred treatment.

A 22-year-old woman with a rare genetic condition was successfully treated to develop normal female characteristics and regular menstruation.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

Female and male AGA are different diseases.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

A boy with GAPO syndrome had hair loss similar to male pattern baldness without hormone issues, possibly due to skin or blood vessel problems.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

A rare gene variant causes sexual development issues in siblings, needing personalized treatment.

More severe hair loss is linked to more sexual dysfunction in both men and women.

A postmenopausal woman had rare symptoms due to a possible ovarian tumor, needing thorough evaluation.